Navigation Links
UCSB develops breakthrough technology in identification of prostate cancer cells
Date:9/19/2011

(Santa Barbara, Calif.) A team of researchers at UC Santa Barbara has developed a breakthrough technology that can be used to discriminate cancerous prostate cells in bodily fluids from those that are healthy. The findings are published this week in the Proceedings of the National Academy of Sciences.

While the new technology is years away from use in a clinical setting, the researchers are nonetheless confident that it will be useful in developing a microdevice that will help in understanding when prostate cancer will metastasize, or spread to other parts of the body.

"There have been studies to find the relationship between the number of cancer cells in the blood, and the outcome of the disease," said first author Alessia Pallaoro, postdoctoral fellow in UCSB's Department of Chemistry and Biochemistry. "The higher the number of cancer cells there are in the patient's blood, the worse the prognosis.

"The cancer cells that are found in the blood are thought to be the initiators of metastasis," Pallaoro added. "It would be really important to be able to find them and recognize them within blood or other bodily fluids. This could be helpful for diagnosis and follow-ups during treatment."

The researchers explained that although the primary tumor does not kill prostate cancer patients, metastasis does. "The delay is not well understood," said Gary Braun, second author and postdoctoral fellow in the Department of Molecular, Cellular, and Developmental Biology. "There is a big focus on understanding what causes the tumor to shed cells into the blood. If you could catch them all, then you could stop metastasis. The first thing is to monitor their appearance."

The team developed a novel technique to discriminate between cancerous and non-cancerous cells using a type of laser spectroscopy called surface enhanced Raman spectroscopy (SERS) and silver nanoparticles, which are biotags.

"Silver nanoparticles emit a rich set of colors when they absorb the laser light," said Braun. "This is different than fluorescence. This new technology could be more powerful than fluorescence."

The breakthrough is in being able to include more markers in order to identify and study unique tumor cells that are different from the main tumor cells, explained Pallaoro. "These different cells must be strong enough to start a new tumor, or they must develop changes that allow them to colonize in other areas of the body," she said. "Some changes must be on the surface, which is what we are trying to detect."

The team is working to translate the technology into a diagnostic microdevice for studying cancer cells in the blood. Cells would be mixed with nanoparticles and passed through a laser, then discriminated by the ratio of two signals.

The two types of biotags used in this research have a particular affinity that is dictated by the peptide they carry on their surface. One type attaches to a cell receptor called neuropilin-1, a recently described biomarker found on the surface membrane of certain cancer cells. The other biotag binds many cell types (both cancerous and non-cancerous) and serves as a standard measure as the cells are analyzed.

In this study, the team mixed the two biotags and added them to the healthy and tumor cell cultures. The average SERS signal over a given cell image yielded a ratio of the two signals consistent with the cells' known identity.

Pallaoro said she believes the most important part of the new technique is the fact that it could be expanded by adding more colors different particles of different colors as more biomarkers are found. The team used a new biomarker discovered by scientists at UCSB and the Sanford Burnham Medical Research Institute.


'/>"/>

Contact: Gail Gallessich
gail.g@ia.ucsb.edu
805-893-7220
University of California - Santa Barbara
Source:Eurekalert  

Related medicine news :

1. USC scientist develops virus that targets HIV
2. JRC develops new testing methods for contaminated sports drinks from Taiwan
3. Carnegie Mellon develops iPhone app that predicts when bus will arrive
4. University of Leicester develops test for classifying force used in bottle stabbings
5. UT Southwestern pediatric urologist develops procedure to eliminate scarring in kidney surgeries
6. In the lab and clinic, VCU Massey develops a new therapy for blood cancers
7. New grant to study how pediatric brain tumor, ependymoma, develops
8. CHEO Research Institute develops secure protocol for data disclosure
9. Queens develops new brain training app for research into aging minds
10. 1 in 5 Kids With Cold Develops Middle Ear Infection: Study
11. Mount Sinai develops first screening tool for war veterans to assess traumatic brain injury
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
UCSB develops breakthrough technology in identification of prostate cancer cells
(Date:3/22/2017)... ... 22, 2017 , ... Chris Humphrey Insurance Agency, a North Carolina firm offering ... coastal plains region, is initiating a charity event to raise support for five year ... with leukemia on a Friday evening in September 2014. At the time, Dillyn was ...
(Date:3/22/2017)... ... March 22, 2017 , ... The Senior Citizens ... and prevent a default on the federal debt — including the debt held by ... growing concern, ” said TSCL in a letter to House and Senate budget leaders. ...
(Date:3/22/2017)... ... March 22, 2017 , ... NYC Chiropractor Dr. Steven Shoshany recently helped host ... its kind in the U.S. and focused on a new protocol for treating pain. ... to New York, and furthermore the first seminar in the country was hosted ...
(Date:3/22/2017)... ... 22, 2017 , ... The National Association for Business Resources (NABR) ... and Brightest in Wellness® companies for 2017. , American Specialty Health (ASH) ... in wellness for its employees. ASH is one of only nine other San Diego ...
(Date:3/20/2017)... ... 2017 , ... New research conducted by The Beryl Institute ... findings initially announced and live streamed at Patient Experience Conference 2017 , ... the challenges and opportunities they are facing and the steps they are taking ...
Breaking Medicine News(10 mins):
(Date:3/22/2017)... , 22. März 2017   ... und weltweit tätige Anbieter von Produkten und ... den Erwerb von EPL Archives Inc. bekannt, ... der Kunden im kompletten Zyklus regulierter Forschung, ... von Proben, Speicherung von Dokumenten und Zusatzdienstleistungen ...
(Date:3/22/2017)... , March 22, 2017  Ablation is ... for a wide range of purposes, from cancerous ... abnormally conducting cardiac tissue in atrial fibrillation and ... is pushing the researchers to innovate and improvise ... The ablation device global market is expected ...
(Date:3/22/2017)... 22, 2017 TapImmune, Inc. ... the development of innovative peptide and gene-based immunotherapeutics ... today announced that it will participate in two ... Glynn Wilson , Chairman and CEO of ... business, clinical pipeline and partnering opportunities for its ...
Breaking Medicine Technology: